Celldex Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2009 | -49.5% | -49.5% | — |
| FY2010 | -3.4% | -3.4% | -2.3% |
| FY2011 | -65.2% | -65.2% | -45.7% |
| FY2012 | -61.7% | -61.7% | -47.1% |
| FY2013 | -25.5% | -25.5% | -23.5% |
| FY2014 | -55.8% | -55.8% | -47.6% |
| FY2015 | -43.8% | -43.8% | -37.7% |
| FY2016 | -48.4% | -48.4% | -33.5% |
| FY2017 | -39.4% | -39.4% | -29.5% |
| FY2018 | -121.9% | -121.9% | -97.0% |
| FY2019 | -54.1% | -54.1% | -41.4% |
| FY2020 | -28.6% | -28.6% | -25.3% |
| FY2021 | -16.8% | -16.8% | -15.9% |
| FY2022 | -34.4% | -34.4% | -31.8% |
| FY2023 | -33.0% | -33.0% | -30.4% |
| FY2024 | -21.1% | -21.1% | -19.9% |
| FY2025 | -49.1% | -49.1% | -44.4% |